The FDA recently finalized a rule that would allow prescription drug importation from Canada in FDA-authorized programs.
The final rule, part of the White House’s Safe Importation Action Plan,...
According to the White House, this strategy would allow Americans to receive the same low prices for prescription medications that are available in other countries.
But many stakeholders have...
Although prices for migraine medications rose by 40 percent through 2017, they sharply declined at the beginning of 2018 and haven’t seen much of an increase since, according to a GoodRx report....
President Trump signed an executive order yesterday to lower prescription drug prices by “putting America first,” but experts are unsure if this move will have a direct impact on rising...
Drug rebates are distorting the market for branded drugs and producing outcomes that may be harmful to both patients and the healthcare system, according to a recent study by the Pioneer Institute.
In...
A study recently published in JAMA Network Open found that nearly one-third of sole-source, off-patent, and off-exclusivity drug products saw major increases in drug prices over any calendar year.
In...
The Trump administration is aiming to lower drug prices by eliminating kickbacks to middlemen, like pharmacy benefit managers (PBMs), and increasing drug importation in three new executive orders...
The German Pharmaceutical Market Restructuring Act (AMNOG) is an example of how a drug pricing strategy can be designed to better align prices with clinical benefit and is an approach the US can take...
The Justice Department announced that pharmaceutical company Novartis agreed to pay $642 million in two separate settlements to resolve healthcare fraud allegations involving False Claims Act (FCA)...
Gilead will price its COVID-19 drug, remdesivir, at $390 per vial to ensure broad and equitable access during the global pandemic, according to an official letter from Gilead chairman and CEO, Daniel...
Pharmaceutical companies significantly increased drug costs for 245 drugs between January 20 and June 20, with more than 75 percent of the drugs impacted directly pertaining to COVID-19, according to a...
Department of Justice (DOJ) recently charged Glenmark Pharmaceuticals Inc. for the it role in antitrust violations from May 2013 to December 2015.
The DOJ’s complaint alleged that the...
Pharmacy benefit manager (PBM) reimbursement for generic drugs significantly varies by medication and plan, and does not respond to price hikes, according to a study from 3 Axis Advisors.
Researchers...
Pharmaceutical Care Management Association (PCMA) president and CEO JC Scott issued a letter to the Trump Administration’s COVID-19 Task Force affirming pharmacy benefit managers’ (PBMs)...
Manufacturers increased prescription drug prices for four drugs commonly used by hospitals after receiving FDA approval, creating an estimated $20.25 billion in additional healthcare spending over...
The Department of Justice recently announced that it has charged generic pharmaceutical company Sandoz Inc. for fixing generic drug prices, rigging bids, and other antitrust...
The US Justice Department announced that pharmaceutical company Sanofi SA agreed to pay $11.85 million to resolve Medicare fraud accusations involving a recent charity kickback probe.
Sanofi...
The net cost of prescription drugs rose over three times faster than the rate of inflation over the last decade, according to researchers from the University of Pittsburgh’s Health Policy...
Two members of the United States Committee on Finance made a final document request to pharmacy benefit manager Express Scripts, owned by Cigna, and warned that failure to comply will result in a...
Members of Congress demand accessible, available, and affordable drug pricing for taxpayer-funded coronavirus (COVID-19) vaccines or treatments, according to an official letter from House Democrats to...
